Current Edition

2017

Shield Therapeutics 2017 Loss Widens On Clinical Trials, Higher Costs

Shield Therapeutics PLC on Wednesday reported significantly widened loss for 2017, as it progresses on Feraccru product study and commercialisation. The specialty pharmaceutical firm reported …

Continue Reading →